Colink Neofuse
Payments companies reported to CMS as associated with Colink Neofuse. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Colink Neofuse, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Colink Neofuse
These are the largest totals companies reported as associated with Colink Neofuse. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Halloran | Leawood, KS | Sports Medicine (Orthopaedic Surgery) | $20,328.34 |
| Norman Waldrop | Birmingham, AL | Foot and Ankle Surgery | $5,000.00 |
| Samuel Adams | Durham, NC | Orthopaedic Surgery | $4,957.23 |
| Mark Easley | Durham, NC | Orthopaedic Surgery | $3,968.96 |
| Martina Randall | Burbank, CA | Foot & Ankle Surgery | $3,500.00 |
| Cody Togher | Naples, FL | Foot & Ankle Surgery | $3,500.00 |
| Gary Simpson | Colorado Springs, CO | Orthopaedic Surgery | $2,546.08 |
| Constantine Demetracopoulos | New York, NY | Foot and Ankle Surgery | $2,413.08 |
| Justin Daigre | Decatur, AL | Foot and Ankle Surgery | $1,868.45 |
| Robert Olson | Gastonia, NC | Foot & Ankle Surgery | $950.57 |
Prescribed Colink Neofuse?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.